As the World Health Organization prepares to recommend that most countries assume that their flu cases are the result of the novel H1N1 swine flu virus, officials are seeing the first signs of resistance to the commonly used antiviral drug Tamiflu -- though so far none that are particularly disturbing.
Meanwhile, the virus is continuing to spread through the Northern Hemisphere this summer -- even though flu normally doesn't spread well in hot weather -- and its effect is growing in the southern half of the globe, which has begun its traditional winter flu season.
Within the next few days, the WHO will suggest that countries with major outbreaks of swine flu move away from laboratory confirmation of cases and toward larger, national indicators of disease, such as the number of people with flu-like symptoms and cases of pneumonia, Dr. Keiji Fukuda, WHO assistant director-general, said Tuesday in a telephone news conference.
The large number of cases in such countries is overwhelming labs and making it "very hard to keep up" with testing, he said. The new guidelines will "ease the burden on laboratories," he said. In most countries with major outbreaks of the virus, 95% or more of total flu cases are being caused by H1N1.
"In countries with no cases, we will continue to recommend that people be tested so the presence of the new virus can be confirmed," Fukuda said. "In all countries, we will continue to stress testing for unusual cases, clusters, unusually severe cases and new symptoms."
But the number of swine-flu-free countries is likely to be small soon. The most recent figures reported to the WHO indicate that more than 98,000 cases have been confirmed in 120 countries, with 440 deaths, though officials estimate the number of actual infections at 10 to 100 times that.
The most recent figures for the United States indicate 33,902 lab-confirmed cases and 170 deaths, but officials at the national Centers for Disease Control and Prevention have estimated that more than 1 million Americans have contracted the virus.
In the last two weeks, health officials have identified three patients -- one each in Denmark, Japan and Hong Kong -- with a virus resistant to Tamiflu, known generically as oseltamivir.
The cases in Denmark and Japan occurred in patients who had been taking the drug prophylactically; the Hong Kong case involved a girl who had traveled from San Francisco and never been given oseltamivir, suggesting that she contracted a resistant virus.
